FY2025 · ended Dec 31, 2025 · Revenue $2.94B, +16.7% YoY · Filed Feb 24, 2026
Globus Medical, Inc. (GMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.9 billion and net income of $537.9 million. Free cash flow was $588.8 million. As of Sep 30, 2026 it held $871.2 million in cash and investments and $108.2 million in total debt.
Revenue (TTM)
$3.14B
+13.4% vs year-ago TTM
Net income (TTM)
$557.64M
+31.6% vs year-ago TTM
Operating cash flow (TTM)
$925.92M
+29.5% vs year-ago TTM
Free cash flow (TTM)
$766.55M
+32.3% vs year-ago TTM
EPS (TTM)
$4.07
+32.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
135.25M
-1.7% vs prior year
Net cash
$762.99M
as of Sep 30, 2026
Operating margin
21.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GMED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Audubon, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1237831
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $1.6B | $1.0B | $958.1M |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M |
| Diluted EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Operating cash flow | $753.4M | $520.6M | $243.5M | $178.5M | $276.3M |
| Free cash flow | $588.8M | $405.2M | $165.2M | $104.4M | $219.4M |
| Total assets | $5.3B | $5.3B | $5.1B | $2.1B | $2.0B |
| Total liabilities | $729.5M | $1.1B | $1.1B | $229.8M | $215.9M |
| Stockholders' equity | $4.6B | $4.2B | $4.0B | $1.8B | $1.7B |
| Cash and investments | $629.1M | $171.8M | $125.9M | $791.4M | $812.9M |
| Total debt | $119.4M | $94.4M | $103.8M | — | $5.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 778 Globus Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.